Afinitor (Everolimus) Approved For Renal Angiomyolipomas By FDA Medical News Today Afinitor (everolimus) has been approved by the FDA for renal angiomyolipomas (non-cancerous kidney tumors) that do not require urgent surgery in patients with TSC (tuberous sclerosis complex). Tuberous sclerosis complex is a very rare genetic condition ... US FDA approves Novartis' Afinitor to treat adult patients with kidney tumours FDA Expands Everolimus Label Novartis' Afinitor Gets FDA Okay for Treating Renal Angiomyolipoma Associated ... |
